Literature DB >> 29804098

Long non-coding RNA-mediated regulation of signaling pathways in gastric cancer.

Wei Zong1, Shaoqing Ju1, Rongrong Jing2, Ming Cui3.   

Abstract

Gastric cancer (GC) is one of the most common cancers globally. Because of the high frequency of tumor recurrence, or metastasis, after surgical resection, the prognosis of patients with GC is poor. Therefore, exploring the mechanisms underlying GC is of great importance. Recently, accumulating evidence has begun to show that dysregulated long non-coding RNAs (lncRNAs) participate in the progression of GC via several typical signaling pathways, such as the AKT and MAPK signaling pathways. Moreover, the interactions between lncRNAs and microRNAs appear to represent a novel mechanism in the pathogenesis of GC. This review provides a synopsis of the latest research relating to lncRNAs and associated signaling pathways in GC.

Entities:  

Keywords:  gastric cancer; long non-coding RNAs; microRNAs; signaling pathways

Mesh:

Substances:

Year:  2018        PMID: 29804098     DOI: 10.1515/cclm-2017-1139

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

1.  LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway.

Authors:  Wei Zong; Wei Feng; Yun Jiang; Yaning Cao; Yuchen Ke; Xin Shi; Shaoqing Ju; Hui Cong; Xudong Wang; Ming Cui; Rongrong Jing
Journal:  Gastric Cancer       Date:  2019-08-26       Impact factor: 7.370

2.  RETRACTED ARTICLE: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2.

Authors:  Dan Sun; Ying Wang; Huan Wang; Yan Xin
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 6.429

3.  Long Noncoding RNA LINC00173 Promotes the Malignancy of Melanoma by Promoting the Expression of IRS4 Through Competitive Binding to microRNA-493.

Authors:  Fan Yang; Pengzhen Lei; Weihui Zeng; Jianwu Gao; Na Wu
Journal:  Cancer Manag Res       Date:  2020-05-05       Impact factor: 3.989

4.  Silencing of Long Non-Coding RNA-HCG18 Inhibits the Tumorigenesis of Gastric Cancer Through Blocking PI3K/Akt Pathway.

Authors:  Fengzhen Ma; Kexiang An; Yuqin Li
Journal:  Onco Targets Ther       Date:  2020-03-18       Impact factor: 4.147

5.  Long Non-Coding RNA AC118344.1 Promotes Gastric Cancer Cell Proliferation, Invasion, and Metastasis via AKT2 and Its Downstream Molecules HK2 and MMP2.

Authors:  Lixia Cai; Yangji Xue; Jianzu Ding; Bin Zheng
Journal:  Cancer Manag Res       Date:  2020-12-08       Impact factor: 3.989

6.  LINC01224 accelerates malignant transformation via MiR-193a-5p/CDK8 axis in gastric cancer.

Authors:  Hui Sun; Jihong Yan; Guangyu Tian; Xiaojun Chen; Wenbo Song
Journal:  Cancer Med       Date:  2021-02       Impact factor: 4.452

7.  LncRNA KCNQ1OT1 (potassium voltage-gated channel subfamily Q member 1 opposite strand/antisense transcript 1) aggravates acute kidney injury by activating p38/NF-κB pathway via miR-212-3p/MAPK1 (mitogen-activated protein kinase 1) axis in sepsis.

Authors:  Haixia Wang; Hongbin Mou; Xiaolan Xu; Changhua Liu; Gang Zhou; Bo Gao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Circular RNA circCOL6A3_030 is involved in the metastasis of gastric cancer by encoding polypeptide.

Authors:  Xiaoge Geng; Jingya Wang; Chenjing Zhang; Xiaolu Zhou; Jiyong Jing; Wensheng Pan
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 9.  Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance.

Authors:  Li Yuan; Zhi-Yuan Xu; Shan-Ming Ruan; Shaowei Mo; Jiang-Jiang Qin; Xiang-Dong Cheng
Journal:  Mol Cancer       Date:  2020-05-27       Impact factor: 27.401

10.  The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2.

Authors:  Dan Sun; Ying Wang; Huan Wang; Yan Xin
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.